American Society of Hematology

Figure 6

Figure 6. Survival rates compared with AML-NOS. EFS (A) and OS (B) in AML-MRC because of cytogenetics or MDS or MDS/MPN history versus AML-NOS.

Survival rates compared with AML-NOS. EFS (A) and OS (B) in AML-MRC because of cytogenetics or MDS or MDS/MPN history versus AML-NOS.

This Feature Is Available To Subscribers Only

Sign In or Create an Account